- Home
- SANW vs HSCS Comparison
SANW vs HSCS Comparison
Compare SANW & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANW
- HSCS
- Stock Information
- Founded
- SANW 1980
- HSCS 2007
- Country
- SANW United States
- HSCS United States
- Employees
- SANW N/A
- HSCS N/A
- Industry
- SANW Farming/Seeds/Milling
- HSCS Medical Specialities
- Sector
- SANW Consumer Staples
- HSCS Health Care
- Exchange
- SANW Nasdaq
- HSCS Nasdaq
- Market Cap
- SANW 4.6M
- HSCS 3.7M
- IPO Year
- SANW 2010
- HSCS 2022
- Fundamental
- Price
- SANW $1.77
- HSCS $3.94
- Analyst Decision
- SANW Strong Buy
- HSCS Strong Buy
- Analyst Count
- SANW 1
- HSCS 2
- Target Price
- SANW $25.00
- HSCS $13.00
- AVG Volume (30 Days)
- SANW 100.5K
- HSCS 187.6K
- Earning Date
- SANW 05-15-2025
- HSCS 07-24-2025
- Dividend Yield
- SANW N/A
- HSCS N/A
- EPS Growth
- SANW N/A
- HSCS N/A
- EPS
- SANW N/A
- HSCS N/A
- Revenue
- SANW $54,993,808.00
- HSCS $4,350.00
- Revenue This Year
- SANW N/A
- HSCS $21,003.45
- Revenue Next Year
- SANW $17.19
- HSCS $533.33
- P/E Ratio
- SANW N/A
- HSCS N/A
- Revenue Growth
- SANW 6.91
- HSCS N/A
- 52 Week Low
- SANW $1.50
- HSCS $2.36
- 52 Week High
- SANW $11.60
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- SANW 31.84
- HSCS 49.70
- Support Level
- SANW $1.50
- HSCS $3.62
- Resistance Level
- SANW $2.15
- HSCS $4.14
- Average True Range (ATR)
- SANW 0.23
- HSCS 0.67
- MACD
- SANW 0.10
- HSCS -0.05
- Stochastic Oscillator
- SANW 25.00
- HSCS 12.15
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.